First at-home test kit for cervical cancer approved by the FDA, company says
3 minute readPublished: Friday, May 9, 2025 at 7:57 pm

**First At-Home Cervical Cancer Test Kit Approved by FDA: A Game Changer for Women's Health**
The U.S. Food and Drug Administration (FDA) has given the green light to the first at-home cervical cancer testing kit, a significant development in women's health. According to Teal Health, the medical device company behind the innovation, the "Teal Wand" allows women to collect their own vaginal samples for HPV testing in the comfort of their homes. This groundbreaking approval offers a convenient alternative to traditional methods, which require visits to a doctor's office or clinic.
The Teal Wand works by allowing women to collect a sample using a swab or brush inserted into the vagina. The sample is then placed in a container and sent to a lab for analysis. The test detects the human papillomavirus (HPV), the primary cause of cervical cancer. Persistent HPV infections can lead to cervical cancer, and early detection is crucial.
This approval comes after a federal panel recommended self-collection of HPV samples to improve screening rates. While the FDA had previously approved self-collection for older HPV tests, those still required the process to be done at a medical facility. The Teal Wand offers true at-home convenience.
Teal Health, based in San Francisco, plans to launch the kits in California next month, with plans to expand to other states. The company is also working with insurance providers to ensure coverage for the test. The kit requires a prescription, which can be obtained through the company's online health providers. This new option has the potential to increase screening rates and improve early detection of cervical cancer, ultimately saving lives.
Keywords: cervical cancer, HPV, at-home test, FDA approved, Teal Wand, women's health, self-collection, vaginal sample, screening, early detection, medical device, prescription, California, insurance coverage